Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13
Published April 9, 2025 · Recall initiated: March 17, 2025
Summary
FDA records drug Class II recall D-0306-2025, published April 9, 2025 and initiated March 17, 2025. Recalling firm: BIOCON PHARMA INC; Status: Ongoing; Reported quantity: 2184 bottles; Lot: Lot#: AVC24035, Exp 03/31/26. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specifications: lower than specifications
What to do
Voluntary: Firm initiated
Get an email if ATORVASTATIN CALCIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ATORVASTATIN CALCIUM
- Manufacturer
- BIOCON PHARMA INC
- Distributor
- U.S.A. nationwide
- UPC
- 0370377080111
- Lot
- Lot#: AVC24035, Exp 03/31/26
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAtorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL LaboratoriesNovember 4, 2026
- FDAAtorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDCOctober 22, 2025
- FDAAtorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90), b). 500-count (NDCOctober 22, 2025
- FDAAtorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottleOctober 22, 2025
- FDATropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mLApril 9, 2025
- FDAVoriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30April 9, 2025
Questions about this recall
Was Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13 recalled?
Yes. FDA published recall D-0306-2025 on April 9, 2025. Reported hazard: Failed dissolution specifications: lower than specifications
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ATORVASTATIN CALCIUM. UPC: 0370377080111.